Determine Return on Investment in Heart Failure Remote Monitoring Program

This is an interventional prevention trial for Heart Failure focused on measuring telemedicine, heart failure, home blood pressure monitoring Read More

Inclusion Criteria:

• Absence of significant vision, hearing, or other communication deficits
• English speaking;
• Capable and willing to give informed consent;
• Participated in the in-patient heart failure class within the last three months. Acceptable candidate for elective, non-emergent, remote monitoring as determined by ordering physician;
• Living in a private home;
• Hospital admission for Heart Failure or decompensation in the previous 12 months
• New York Heart Association (NYHA) classes II-IV, as assigned by the nurse researcher, trained by a cardiologist
• Cardiac aetiology: ischaemic, idiopathic, hypertensive, or valvular
• Left ventricular ejection fraction <40% s an index of systolic dysfunction, combined or not with a left ventricular filling pattern supporting the presence of diastolic dysfunction, according to the American College of Cardiology/American Heart Association Guidelines for chronic heart failure.

or

• NYHA class II-III who had an ejection fraction >40% and evidence of diastolic left ventricular dysfunction.
• Optional subject with a diagnosis of diabetes (indicated by HbA1c >7).

Exclusion Criteria:

• Currently involved in other investigational clinical trials (unless permission is granted by other study PI);
• Females who are pregnant, planning to become pregnant within 3 months, or lactating;
• Requirement for emergent placement other than private home (subject's condition would be compromised if there is a delay in placement).
• Myocardial infarction, revascularization or Implantable Cardioverter Defibrillator (ICD) implantation in the previous 6 months angina or objective myocardial ischaemia requiring future revascularization implanted ventricular or atrial pacemaker (except dual chamber ICD pacemakers with good sinus activity);
• End-stage heart failure requiring regular inotropic drug infusions;
• Chronic renal failure requiring dialysis treatment and
• Unstable angina.